Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infants

Bingjie Wang; Meghan A. Koch

Cell Reports Medicine (Jun 2021)

Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infants

Bingjie Wang,
Meghan A. Koch

Affiliations

Bingjie Wang: Molecular and Cellular Biology Program and Medical Scientist Training Program, University of Washington, Seattle, WA 98195, USA; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Meghan A. Koch: Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Department of Immunology, University of Washington, Seattle, WA 98109, USA; Corresponding author

Journal volume & issue: Vol. 2, no. 6
p. 100324

Abstract

Read online

Necrotizing enterocolitis (NEC) is an intestinal disorder that disproportionately affects premature infants and lacks in effective therapeutics. Mihi and colleagues1 demonstrated that the cytokine interleukin-22 promotes intestinal epithelial regeneration and reduces disease severity in an experimental model of NEC.

Published in Cell Reports Medicine

ISSN: 2666-3791 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Medicine (General)
Website: https://www.cell.com/cell-reports-medicine

About the journal